This paper reviews 3 recent studies from different clinics correlating
psychotic symptoms with phases of the menstrual cycle in women with s
chizophrenia. The aim of the paper is to focus on the estrogen protect
ion hypothesis which would suggest that low estrogen phases correlate
with more severe symptoms, and high estrogen phases correlate with les
s severe symptoms. Although the methodology of the 3 studies was diffe
rent, the hypothesis was essentially upheld, High levels of estrogens
protect against symptom exacerbations in women with schizophrenia, A c
orollary to this finding is that, for optimal efficacy and safety, neu
roleptic doses could be reduced at certain times of the month and incr
eased at others.